A novel immune checkpoint pathway in human prostate cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210376
- Recipient
-
Albert Einstein College Of Medicine UEI H6N1ZF5HJ2G3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,260,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Bronx, NY 10461, USA
Award details come from USAspending.gov.
About this award
The Albert Einstein College of Medicine was awarded a $1,260,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into "A NOVEL IMMUNE CHECKPOINT PATHWAY IN HUMAN PROSTATE CANCER" from July 1, 2022 to June 30, 2025.
The Military Medical Research and Development program aims to transform health care for service members and the public through innovative biomedical research. This award will further those goals by investigating a novel immune checkpoint pathway that may lead to medical solutions for prostate cancer. The research supported by this funding seeks to advance scientific understanding and potentially improve outcomes for those with this disease.
Quick answers
Who received award W81XWH2210376?
W81XWH2210376 was awarded to Albert Einstein College Of Medicine by Medical Command (Department of the Army) on July 1, 2022.
How much is award W81XWH2210376 worth?
$1,260,000 has been obligated on W81XWH2210376.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award